in patients with atherosclerotic renal-artery stenosis. This multicenter, randomized, unblinded clinical trial was designed and conducted by the members of the ASTRAL writing committee and the ...

41 Balloon angioplasty appears to be less effective for atherosclerotic renal-artery stenosis than for fibromuscular dysplasia. In three multicenter trials of balloon angioplasty (without stenting ...

So these patients were unlikely have been referred for consideration in ASTRAL. "The trial population was ... vs optimal medical therapy in renal-artery-stenosis patients whose doctors believe ...

Thus, the identification of an intervention that can delay, or even prevent, the decline in renal function is of medical importance. The overall design of the ASTRAL trial is shown in Figure 1.

The ASTRAL trial is being reported today in a Late ... “For 15 years we’ve had the wherewithal to fix renal artery stenosis and restore patency of the renal artery,” said Philip A.

the lack of any clear benefit of stenting and the above mentioned complications suggest that patients with renal artery stenosis should be treated with medical therapy alone. The ASTRAL trial ...

Atherosclerotic renal artery stenosis is progressive and ... while offering supportive results, recent trials including DRASTIC, STAR and ASTRAL have suggested that there is no advantage of ...

(HealthDay News) — For patients with atherosclerotic renal artery stenosis (ARAS), the strength ... found that in 5 of 7 randomized controlled trials (RCTs), there was similar blood pressure ...

Two randomized trials, ASTRAL and STAR have suggested that renal artery stenting ... is that in patients with truly drug-resistant hypertension and significant renal artery stenosis, renal artery ...

More than 90% of the time, renal artery stenosis is caused by atherosclerosis, a process in which plaque made up of fats, cholesterol, and other materials builds up on the walls of the blood ...